Medical Device Procurement in the Philippines: A Supplier's Guide [2026]

The Philippines is one of Southeast Asia's most dynamic medical device markets — and one of the most overlooked by suppliers outside the region. With a population of 115 million, a fast-expanding public health insurance system under the Universal Health Care Act (Republic Act 11223), and significant government investment in hospital infrastructure, the Philippines represents a substantial and growing procurement opportunity. Market size is estimated at USD 2.2 billion in 2026, with annual growth of 12–15% driven primarily by public sector expansion.

For foreign medical device manufacturers, market access requires understanding two parallel systems: the Food and Drug Administration Philippines (FDA Philippines) as the regulatory gateway, and the Philippine Government Electronic Procurement System (PhilGEPS) as the primary channel for public hospital tender opportunities. This guide covers both, along with the compliance requirements, evaluation criteria, and common pitfalls that determine tender outcomes.

Regulatory authority: FDA Philippines

The Food and Drug Administration Philippines (FDA Philippines, formally the FDAP) operates under the Department of Health (DOH). It regulates medical devices under the Food and Drug Administration Act of 2009 (Republic Act 9711) and its Implementing Rules and Regulations for Medical Devices (Administrative Order 2019-0003 and subsequent amendments).

The Philippines adopted the ASEAN Medical Device Directive (AMDD) risk classification framework, aligning Philippine medical device regulation with the broader ASEAN harmonisation initiative. Philippine device classification mirrors the four-class system used across ASEAN member states:

Class	Risk level	Examples
Class A	Low risk	Bandages, tongue depressors, non-sterile single-use devices
Class B	Low-medium risk	Hypodermic needles, surgical gloves, ultrasound equipment
Class C	Medium-high risk	Ventilators, haemodialysis machines, powered wheelchairs
Class D	High risk	Implantable pacemakers, drug-eluting stents, absorbable implants

License to Operate and Certificate of Product Registration

Foreign medical device manufacturers must establish market access through two FDA Philippines documents: a License to Operate (LTO) for the local importer or distributor, and a Certificate of Product Registration (CPR) for each device. Both are mandatory preconditions for participating in any public hospital tender.

License to Operate (LTO)

The LTO is required by the local entity — importer, distributor, or local subsidiary — that brings devices into the Philippine market. Requirements include Philippine business registration (DTI or SEC), FDA application with premises inspection, warehouse and distribution facilities meeting Good Distribution Practice (GDP) standards, and a designated responsible person with regulatory qualifications. LTO renewal is annual — an expired LTO disqualifies the local entity from tendering, and any product supply during a lapsed LTO period constitutes an unlicensed activity.

Certificate of Product Registration (CPR)

Each medical device model requires a separate CPR. The registration pathway depends on device class:

• Class A: Notification pathway — submission of basic product information and a conformity declaration. Processing time: 4–8 weeks.
• Class B: Full registration with technical dossier — includes conformity evidence from your home regulator (CE marking, FDA 510(k), TGA, PMDA, or Health Canada accepted as supporting documentation). Processing time: 3–6 months.
• Class C: Full registration with additional clinical data requirements. Processing time: 6–12 months.
• Class D: Most stringent pathway; may require local clinical validation. Processing time: 9–18 months.

CPR validity is typically 5 years for Class B–D. Renewal must be initiated at least 6 months before expiry — hospitals frequently verify CPR currency during tender evaluation, and an expired CPR is an automatic disqualification in DOH and PhilHealth-funded tenders. The most common pitfall for foreign manufacturers: assuming CE marking or FDA 510(k) clearance replaces Philippine registration. These are accepted as supporting evidence only — they can materially accelerate FDA Philippines review for Class B devices but do not substitute for a CPR.

PhilGEPS: the national procurement platform

The Philippine Government Electronic Procurement System (PhilGEPS) at philgeps.gov.ph is the mandatory procurement platform for all Philippine government agencies, including DOH-managed hospitals, state universities, local government units (LGUs), and government-owned corporations. All public hospital tender notices, bid documents, contract awards, and post-bid announcements are published on PhilGEPS.

PhilGEPS registration

Suppliers or their local partners must register on PhilGEPS before bidding. For contracts above PHP 500,000, Platinum Membership is required — this includes uploading all eligibility documents (business registration, LTO, CPR copies, financial statements) to the portal. The resulting PhilGEPS number must appear on all bid submissions.

Procurement procedure types

Philippine public procurement follows the Government Procurement Reform Act (Republic Act 9184), which prescribes several procurement methods relevant to medical devices:

• Competitive Bidding: The standard method for contracts above the threshold. A mandatory two-stage process: pre-bid conference, then sealed bid submission with post-qualification verification.
• Shopping: For small-value procurement (typically under PHP 1 million). Direct comparison of at least three quotations from registered suppliers.
• Negotiated Procurement: For emergency purchases, failed bidding situations, or sole-source situations. Requires specific justification and approvals.
• Framework Agreement: Multi-year supply arrangements for frequently purchased items. PhilHealth-funded hospitals use framework agreements extensively for high-volume device categories.

Public procurement structure

Philippine public hospital procurement is fragmented across several entities, each with its own procurement authority:

• Department of Health (DOH) central procurement: Large capital equipment, DOH retained hospitals (Philippine General Hospital, Quirino Memorial Medical Center, East Avenue Medical Center, and others), and consolidated procurement through the Procurement Service (PS-DBM) for common-use supplies.
• PhilHealth: The national health insurance fund does not directly procure devices but funds hospital procurement decisions. Universal Health Care Act expansion has significantly increased PhilHealth coverage and therefore the device procurement budget available to hospitals in its network.
• Local Government Units (LGUs): Provincial, city, and municipal hospitals procure independently under their own authority. LGU hospital procurement represents a large share of total public procurement volume but is highly fragmented — 82 provinces, 145 cities, and over 1,500 municipalities each maintain separate Bids and Awards Committees (BACs).
• State Universities and Colleges (SUCs): University hospitals, including UP-Philippine General Hospital, procure independently through their own institutional BAC.

Tender compliance requirements

Philippine government tenders for medical devices require a standard set of eligibility documents, verified at the post-qualification stage after bids are opened:

• PhilGEPS number and Platinum Membership certificate
• Certificate of Product Registration (CPR) — must be valid at time of bidding and throughout the contract period
• License to Operate (LTO) — for the local distributor or importer
• Manufacturer's authorisation letter — a notarized letter from the foreign manufacturer designating the local supplier as authorised distributor for the specific products being tendered. Generic or expired authorisation letters are routinely rejected during post-qualification.
• Omnibus Sworn Statement — under RA 9184, certifying eligibility, no conflict of interest, and procurement law compliance
• Financial eligibility documents — audited financial statements from the past two fiscal years demonstrating financial capacity proportionate to the contract value
• Technical specifications compliance matrix — a point-by-point table matching each tender specification parameter against your device's documented performance data

Post-qualification verification in Philippine procurement is thorough: Bids and Awards Committees request original documents, may conduct site visits for high-value capital equipment, and verify regulatory status directly with FDA Philippines. Discrepancies at post-qualification — including expired CPRs, incorrect specification claims, or incorrectly scoped authorisation letters — result in disqualification even after the lowest price bid has been identified.

Tender evaluation: lowest compliant bid

Philippine competitive bidding for medical devices uses a lowest compliant bid evaluation methodology: all technically compliant submissions are ranked by price, and the lowest price that passes all eligibility and specification requirements wins. This differs fundamentally from EU MEAT criteria or NHS Value-Based Procurement — there is no life-cycle cost scoring, social value weighting, or innovation premium in standard Philippine competitive bidding.

The implication: specification compliance is binary, not scored. A device that meets 95% of the technical specification fails and is disqualified; a device that meets 100% wins on price. Thorough specification matching — verifying every technical parameter against your device's documented performance characteristics in the CPR and IFU — is the most critical element of Philippine tender preparation. For a deeper look at how AI-assisted spec matching handles this, see our guide to spec matching for tender teams.

Common pitfalls for foreign manufacturers

• CPR expiry during bid evaluation: Philippine tender evaluation periods — from bid opening through post-qualification through contract award — can stretch 2–4 months. A CPR valid at bid opening but expired during evaluation will disqualify the bid at post-qualification. Track CPR expiry dates 12 months ahead and initiate renewal well in advance of any expected tender submission.
• Incorrect or generic authorisation letters: The manufacturer authorisation letter must cover the specific products, the specific tender, and the contract period. Generic authorisations are routinely rejected. Prepare a dedicated notarised authorisation letter for each significant tender.
• LGU tender monitoring gap: Most foreign manufacturers focus on DOH central tenders visible on PhilGEPS. LGU hospital tenders are also published on PhilGEPS but with varying metadata quality. An estimated 60–70% of Philippine public hospital device procurement volume flows through LGU hospitals — missing this segment means missing most of the market.
• Narrow specification exclusion: Philippine tender specifications are sometimes written around an incumbent supplier's parameters. Review specifications carefully for criteria that appear specifically tailored to a competitor, and file a formal clarification request with the BAC during the pre-bid period if a specification appears to exclude technically capable alternatives without clinical justification.

How MedStrato helps Philippines-focused tender teams

The Philippines market is compliance-heavy and documentation-intensive. CPR and LTO currency, authorisation letter accuracy, specification compliance, and PhilGEPS registration status are all potential disqualification triggers — and the fragmentation of procurement across hundreds of LGU entities makes manual monitoring effectively impossible for a lean team.

MedStrato's Philippines coverage includes automated monitoring of PhilGEPS across all government agencies and LGU entities, CPR and LTO expiry tracking with advance renewal alerts, specification compliance matrix generation mapping tender requirements against registered device parameters, and eligibility document checklist generation for each submission. Learn more at MedStrato's tender tracking features or explore our guides for Singapore and Malaysia to build a complete ASEAN market picture. Book a demo to see Philippine PhilGEPS monitoring in practice.